2C0

baclofen

Created:	2013-09-19
Last modified:	2020-06-05

Find Related PDB Entry
3 entries where 2C0 is found as a standalone ligand

Find related ligands: Help
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	26
Chiral Atom Count	1
Bond Count	26
Aromatic Bond Count	6

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	baclofen
Synonyms	(3R)-4-amino-3-(4-chlorophenyl)butanoic acid
Systematic Name (OpenEye OEToolkits)	(3R)-4-azanyl-3-(4-chlorophenyl)butanoic acid
Formula	C₁₀ H₁₂ Cl N O₂
Molecular Weight	213.661
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Clc1ccc(cc1)C(CN)CC(=O)O
SMILES	CACTVS	3.385	NC[CH](CC(O)=O)c1ccc(Cl)cc1
SMILES	OpenEye OEToolkits	1.7.6	c1cc(ccc1C(CC(=O)O)CN)Cl
Canonical SMILES	CACTVS	3.385	NC[C@H](CC(O)=O)c1ccc(Cl)cc1
Canonical SMILES	OpenEye OEToolkits	1.7.6	c1cc(ccc1[C@@H](CC(=O)O)CN)Cl
InChI	InChI	1.03	InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)/t8-/m0/s1
InChIKey	InChI	1.03	KPYSYYIEGFHWSV-QMMMGPOBSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB08891
Name	Arbaclofen
Groups	investigational
Description	Arbaclofen, or STX209, is the R-enantiomer of baclofen. It is believed to be a selective gamma-amino butyric acid type B receptor agonist, and has been investigated as a treatment for autism spectrum disorder and fragile X syndrome in randomized, double blind, placebo controlled trials. It has also been investigated as a treatment for spasticity due to multiple sclerosis and spinal cord injury. Arbaclofen was investigated as a treatment for gastroesophageal reflux disease (GERD); however, with disappointing results.
Synonyms	Arbaclofen (R)-Baclofen (R)-4-amino-3-(4-chlorophenyl)butanoic acid
Indication	Investigated in clinical trials as a potential treatment for spasticity in multiple sclerosis, autism spectrum disorder, and social withdrawal in fragile X syndrome.
CAS number	69308-37-8

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Gamma-aminobutyric acid type B receptor subunit 1	MLLLLLLAPLFLRPPGAGGAQTPNATSEGCQIIHPPWEGGIRYRGLTRDQ...	unknown	agonist
Gamma-aminobutyric acid type B receptor subunit 2	MASPRSSGQPGPPPPPPPPPARLLLLLLLPLLLPLAPGAWGWARGAPRPP...	unknown	agonist

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource Name	Reference
Pharos	CHEMBL301742
PubChem	44602, 6918881
ChEMBL	CHEMBL301742
CCDC/CSD	WONSIE, CRBMZC10, WONSIE01, LUSXII01, LUSXII, LUSXOO, YIPLAN, LUSXEE, RUWGOG, AQEKUE, LABKAE, LABKEI, LABJUX, LABJIL, FESCUF, FESDAM, FESDEQ
COD	4510988, 4501801